Previous Article | Next Article ![]()
Mol. Cell. Biol., 06 1996, 3179-3186, Vol 16, No. 6
M Pomerance, MN Thang, B Tocque and M Pierre
The Ras-GTPase-activating protein (RasGAP) is an important modulator of
p21ras - dependent signal transduction in Xenopus oocytes and in mammalian
cells. We investigated the role of the RasGAP SH3 domain in signal
transduction with a monoclonal antibody against the SH3 domain of RasGaP.
This antibody prevented the activation of the maturation- promoting factor
complex (cyclin B-p34cdc2) by oncogenic Ras. The antibody appears to be
specific because as little as 5 ng injected per oocyte reduced the level of
Cdc2 activation by 50% whereas 100 ng of nonspecific immunoglobulin G did
not affect Cdc2 activation. The antibody blocked the Cdc2 activation
induced by oncogenic Ras but not that induced by progesterone, which acts
independently of Ras. A peptide corresponding to positions 317 to 326 of a
sequence in the SH3 domain of human RasGAP blocked Cdc2 activation, whereas
a peptide corresponding to positions 273 to 305 of a sequence in the
N-terminal moiety of the SH3 domain of RasGAP had no effect. The antibody
did not block the mitogen-activated protein (MAP) kinase cascade
(activation of MAPK/ERK kinase [MEK], MAP kinase, and S6 kinase p90rsk).
Surprisingly, injection of the negative MAP kinase mutant protein ERK2 K52R
(containing a K-to-R mutation at position 52) blocked the Cdc2 activation
induced by oncogenic Ras as well as blocking the activation of MAP kinase.
Thus, MAP kinase is also implicated in the regulation of Cdc2 activity. In
this study, we further investigated the regulation of the synthesis of the
c-mos oncogene product, which is necessary for the activation of Cdc2. We
report that the synthesis of the c-mos oncogene product, which is necessary
for the activation antibody to the SH3 domain of RasGAP and by injecting
the negative MAP kinase mutant protein ERK2 K52R. These results suggest
that oncogenic Ras activates two signaling mechanisms: the MAP kinase
cascade and a signaling pathway implicating the SH3 domain of RasGAP. These
mechanisms might control Mos protein expression implicated in Cdc2
activation.
Copyright © 1996, American Society for Microbiology
The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation
Unite de Recherche sur la Glande Thyroide et la Regulation Hormonale, U96 Institut National de la Sante et de la Recherche Medicale, Le Kremlin-Bicetre, France.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»